No Data
No Data
Chemed Insider Sold Shares Worth $1,197,620, According to a Recent SEC Filing
Oppenheimer Maintains Chemed(CHE.US) With Buy Rating, Maintains Target Price $650
Oppenheimer analyst Michael Wiederhorn maintains $Chemed(CHE.US)$ with a buy rating, and maintains the target price at $650.According to TipRanks data, the analyst has a success rate of 69.3% and a
Oppenheimer Sticks to Its Buy Rating for Chemed (CHE)
These Are the Mid-caps That Could Perform Best During 'Downturn' Regimes – BofA
Press Release: Chemed To Report Third-Quarter 2024 Earnings October 29, Related Conference Call To Be Held On October 30
Here's Why Chemed Corporation (CHE) Declined in Q2